Floatz logo

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A

Esophageal Squamous Cell Carcinoma

Peking UniversitySmall moleculePhase 2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Esophageal Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Neonc Technologies, Inc.
Phase 3BB
FLUOROURACILUM
AstraZeneca
Phase 3BB
Cyclophosphamide
Rondo Therapeutics
Phase 3B
Pembrolizumab
GV20 Therapeutics
Phase 3B
Epirubicin
Rondo Therapeutics
Phase 3B

View all 50 →

Same molecule, other indications

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:

Liver NeoplasmsDormant
B
Indicative ·
62 / 100
View asset →
Stage II Pancreatic Cancer AJCC v8Dormant
B
Indicative ·
59 / 100
View asset →
Liver MetastasisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →